Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sonoma Pharmaceuticals Inc.
DescriptionAntipruritic hydrogel based on Microcyn technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPilot
Standard IndicationDermatitis
Indication DetailsTreat atopic dermatitis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today